RT Book, Section
A1 Kim, Chul
A1 Giaccone, Giuseppe
A2 Boyiadzis, Michael M.
A2 Fojo, Tito
SR Print(0)
ID 1187885352
T1 Thymic Malignancies
T2 Hematology-Oncology Therapy, 3e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260117400
LK hemonc.mhmedical.com/content.aspx?aid=1187885352
RD 2024/04/19
AB EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence:0.13  cases  per  100,000  (0.2–1.5%  of  all  malignancies)Stage  at  presentation:  (Masaoka  Staging  System)Median  age:40–60  yearsMale  to  female  ratio:1:1Stage  I:32%Engels  EA,  Pfeiffer  RM.  Int  J  Cancer  2003;105:546–551Schmidt-Wolf  IGH  et  al.  Ann  Hematol  2003;82:69–76Tomiak  EM,  Evans  WK.  Crit  Rev  Oncol  Hematol  1993;15:113–124Stage  II:23%Stage  III:34%Stage  IV:11%